DPP-4 Enhances The Body: A Case Study

Satisfactory Essays
5-Dipeptidyl peptidase 4 (DPP-4) inhibitors DPP-4 inhibitors enhance the body's own ability to control blood glucose by increasing the active levels of incretin: glucagen like peplide l (GLP-l), glucose- dependent insulintropic polypeptide (GIP) hormones in the body. Their mechanism of action is distinct from any existing class of oral glucose-lowering agents. They control elevated blood glucose by triggering pancreatic insulin secretion, suppressing pancreatic glucagon secretion, and signaling the liver to reduce glucose production (Barnett, 2006).
Get Access